Lv1
60 积分 2025-09-11 加入
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
20小时前
待确认
The Influence of Charge Distribution on Self-Association and Viscosity Behavior of Monoclonal Antibody Solutions
7天前
已完结
Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
7天前
已完结
Differential expression and regulation of the human CD8α and CD8β chains
11天前
已完结
Expression of different CD8 isoforms on distinct human lymphocyte subpopulations
12天前
已完结
Construction of Human Antibody Gene Libraries and Selection of Antibodies by Phage Display
13天前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
19天前
已完结
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
19天前
已完结
Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial
19天前
已完结
皖公网安备34019202002308
